West Pharmaceutical Services

WST • NYSE •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $695,400 $732,000 $747,400 $753,800
Gross Profit 230,200 278,200 288,300 291,400
EBITDA 158,400 214,000 218,600 220,600
EBIT 122,800 178,100 182,900 186,500
Net Income 115,300 137,000 161,300 155,100
Net Change In Cash 695,400 732,000 747,400 753,800
Cost of Revenue -89,700
Free Cash Flow 27,600 130,400 134,300 93,800
Cash 601,800 853,900 898,600 796,300
Basic Shares 74,300 75,000 75,300 75,400

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $2,949,800 $2,886,900 $2,831,600 $2,146,900
Gross Profit 1,129,200 1,136,200 1,175,800 767,800
EBITDA 875,700 854,600 878,400 517,200
EBIT 738,400 734,000 752,300 406,900
Net Income 593,400 585,900 661,800 346,200
Net Change In Cash 2,949,800 2,886,900 2,831,600 2,146,900
Cost of Revenue 142,200 147,100 176,400
Free Cash Flow 414,500 439,400 330,600 298,100
Cash 853,900 894,300 762,600 615,500
Basic Shares 75,300 75,800 76,300 75,800

Earnings Calls

Quarter EPS
2024-03-31 $1.56
2023-12-31 $1.83
2023-09-30 $2.16
2023-06-30 $2.11